SLC35E1
Solute carrier family 35 member E1
Also known as: FLJ14251, S35E1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96K37
- Gene
- SLC35E1
- Ensembl
- ENSG00000127526
- Chromosome
- 19
- Canonical length
- 410 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
Predicted to enable antiporter activity. Predicted to be involved in transmembrane transport. Located in Golgi apparatus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
410 residues, UniProt reviewed canonical sequence.
>Q96K37|SLC35E1
1 MAAAAVGAGH GAGGPGAASS SGGAREGARV AALCLLWYAL SAGGNVVNKV ILSAFPFPVT
61 VSLCHILALC AGLPPLLRAW RVPPAPPVSG PGPSPHPSSG PLLPPRFYPR YVLPLAFGKY
121 FASVSAHVSI WKVPVSYAHT VKATMPIWVV LLSRIIMKEK QSTKVYLSLI PIISGVLLAT
181 VTELSFDMWG LVSALAATLC FSLQNIFSKK VLRDSRIHHL RLLNILGCHA VFFMIPTWVL
241 VDLSAFLVSS DLTYVYQWPW TLLLLAVSGF CNFAQNVIAF SILNLVSPLS YSVANATKRI
301 MVITVSLIML RNPVTSTNVL GMMTAILGVF LYNKTKYDAN QQARKHLLPV TTADLSSKER
361 HRSPLEKPHN GLLFPQHGDY QYGRNNILTD HFQYSRQSYP NSYSLNRYDVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC35E1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 9
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 21 nTPM
- skeletal muscle: 18 nTPM
- salivary gland: 15 nTPM
- parathyroid gland: 14 nTPM
- stomach: 13 nTPM
- tongue: 13 nTPM
Single-cell type
- platelets: 9.8 nCPM
- innate lymphoid cells: 5.4 nCPM
- prostatic glandular cells: 5.1 nCPM
- thymic myoid cells: 4.1 nCPM
- retinal ganglion cells: 3.9 nCPM
- parietal cells: 3.5 nCPM
Immune cell
- eosinophil: 3.2 nTPM
- memory B-cell: 2.2 nTPM
- non-classical monocyte: 2 nTPM
- basophil: 1.8 nTPM
- MAIT T-cell: 1.8 nTPM
- NK-cell: 1.8 nTPM
Brain region
- thalamus: 35 nTPM
- cerebral cortex: 29 nTPM
- choroid plexus: 29 nTPM
- midbrain: 29 nTPM
- amygdala: 28 nTPM
- pons: 26 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.65
- gnomAD pLI
- 0.13
- gnomAD missense Z
- 1.48
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC35E1 as an antibody target. Whether an autoantibody or antibody against SLC35E1 could matter depends on whether native SLC35E1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC35E1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLC35E1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...